The Artima Developer Community
Articles | News | Weblogs | Books | Forums
Artima Forums | Articles | Weblogs | Java Answers | News
Sponsored Link •

Java Buzz Forum
Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3...

0 replies on 1 page.

Welcome Guest
  Sign In

Go back to the topic listing  Back to Topic List Click to reply to this topic  Reply to this Topic Click to search messages in this forum  Search Forum Click for a threaded view of the topic  Threaded View   
Previous Topic   Next Topic
Flat View: This topic has 0 replies on 1 page
Angsuman Chakraborty

Posts: 19816
Nickname: angsuman
Registered: Dec, 2003

Angsuman Chakraborty is the CEO and Chief Architect at Taragana
Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3... Posted: Jul 17, 2005 10:48 AM
Reply to this message Reply

This post originated from an RSS feed registered with Java Buzz by Angsuman Chakraborty.
Original Post: Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3...
Feed Title: Simple Thoughts on Java
Feed URL: http://sedoparking.com/search/registrar.php?domain=®istrar=sedopark
Feed Description: News and views as a Software Architect and Entepreneur on Java and related Technologies. 		Latest Java Buzz Posts
Latest Java Buzz Posts by Angsuman Chakraborty
Latest Posts From Simple Thoughts on Java

Advertisement
The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising. There are not many instances where you can stop an autoimmune disease in its tracks," said Dr. Richard Insel, executive vice president for [...]

Read: Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3...

Topic: TechEd '05 EMEA. Previous Topic   Next Topic Topic: FireFox trick to kill unwanted images/ads
Sponsored Links


Google
  Web Artima.com   

Copyright © 1996-2019 Artima, Inc. All Rights Reserved. - Privacy Policy - Terms of Use